BIOORGANIC CHEMISTRY

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

BIOORG CHEM

ISSN / eISSN

0045-2068 / 1090-2120

Aims and Scope

Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.

For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.

The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.

Subject Area

CHEMISTRY, ORGANIC

BIOCHEMISTRY & MOLECULAR BIOLOGY

CiteScore

9.50

View Trend

CiteScore Ranking

Category	Quartile	Rank
Chemistry - Organic Chemistry	Q1	#19/197
Chemistry - Drug Discovery	Q1	#25/156
Chemistry - Biochemistry	Q1	#70/428
Chemistry - Molecular Biology	Q1	#83/380

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE	Q2
CHEMISTRY, ORGANIC - SCIE	Q1

H-index

Country/Area of Publication

UNITED STATES

Publisher

Academic Press Inc.

Publication Frequency

Bimonthly

Year Publication Started

1971

Annual Article Volume

679

Open Access

Contact

ACADEMIC PRESS INC ELSEVIER SCIENCE, 525 B ST, STE 1900, SAN DIEGO, USA, CA, 92101-4495

Popular journals in the same field
Recent articles

Integration of biophysical and biological approaches to validate fragment-like compounds targeting l,d-transpeptidases from Mycobacterium tuberculosis: (2023) Gerardo Andres Libreros-Zúñiga, Danilo Pavão e Pavão, Vinicius de Morais Barroso, Nathalya Cristina de Moraes Roso Mesquita, Saulo Fehelberg Pinto Bra...

Lindenane sesquiterpenoid dimers from Chloranthus japonicus improve LDL uptake by regulating PCSK9 and LDLR: (2023) Pengju Guo, Tong Chen, Xianggang Hu, Yelin Duan, Liu Zheng, Gaoxiang Du, Qing Wang, Aoxue Ding, Guoqing Qin, Yihan Chen, Wenqiong Wang, Qing Mu, Lijia...

Identification of novel 3-aryl-1-aminoisoquinolines-based KRASG12C inhibitors: rational drug design and expedient construction by C-H functionalization/annulation: (2023) Zirong Gong, Yu Zhao, Buyi Xu, Zhou Yang, Boquan Ren, Han Yang, Chengfu Zeng, Renqiang Chen, Yan-Jun Xu, Qing Li

Corrigendum to “LC/HRESI-MS/MS screening, phytochemical characterization, and in vitro antioxidant and cytotoxic potential of Jatropha integerrima Jacq. extracts” [Bioorganic Chem. 140 (2023) 106825 pages: 1-11]: (2023) Mohamed Marzouk, Shimaa M. Khalifa, Amal H. Ahmed, Ahmed M. Metwaly, Hala Sh. Mohammed, Hanan A.A. Taie

Mechanisms of polydatin against spinal cord ischemia–reperfusion injury based on network pharmacology, molecular docking and molecular dynamics simulation: (2023) Zhicheng Sun, Yuanqing Wang, Xiaoyang Pang, Xiyang Wang, Hao Zeng

Monoterpenoid indole alkaloid dimers from the Melodinus axillaris induce G2/M phase arrest and apoptosis via p38 MAPK activation in HCT116 cells: (2023) Kaicheng Du, Xingyao Li, Changwei Zheng, Lantao Lai, Mingyi Shen, Yumeng Wang, Dali Meng

Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis: (2023) Jiaxin Liao, Yuqing Zhang, Minying Huang, Zhijun Liang, Yao Gong, Ben Liu, Yuling Li, Jiaxi Chen, Wei Wu, Zunnan Huang, Jing Sun

Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease: (2023) Wandong Liu, Juan Wang, Suyun Wang, Kairui Yue, Yu Hu, Xiaochun Liu, Lihao Wang, Shengbiao Wan, Ximing Xu

Targeting the epigenetic reader “BET” as a therapeutic strategy for cancer: (2023) Abhishek Wahi, Namish Manchanda, Priti Jain, Hemant R Jadhav

Lysosome-targeted fluorescent probes: Design mechanism and biological applications: (2023) Xiangning Duan, Qin Tong, Chengxiao Fu, Linxi Chen

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

The speed is average, and it takes about a month to receive the review comments (one acceptance and one minor revision. The reviewer who accepted only wrote a generic introduction? Did they submit without completing it?). Because there are some parts in it that need to be supplemented with additional data, the revision time is longer (about one and a half months)... (due to the pandemic, my lovely juniors helped me with the supplementation). After returning the revised manuscript, the editor sent it to a third reviewer (about twenty days), and then issued an acceptance letter (with some minor revision suggestions and various procedures). Approximately one month after acceptance, it was published online. From submission to acceptance letter, it took about three months, and about four months to be published online.
The editor was very nice throughout the entire process, who is an Italian aunt.
If BMC doesn't accept it and I have to revise and submit to E***, I will be able to obtain my degree on time U•ェ•*U.

2021-02-02

I submitted the paper on April 1st last year, and was notified of major revisions a few weeks later. After receiving the revision comments, I realized that the reason for the paper going back to "under review" from "required" on April 10th was because one reviewer recommended acceptance while another recommended rejection, and the third reviewer speculated that it was the editor's decision. Due to the lack of chemical raw materials, I didn't revise the paper until August 30th. I felt that the editor was very nice and recognized the value of the paper, as they readily agreed to a one-month extension. After revising, the paper was accepted within three weeks. I initially thought that it would be difficult for the paper to be accepted as the journal is of high quality and the paper focused more on biology, with weaker aspects in chemical synthesis. So, in summary, my feeling is that the paper needs to cater to the journal's development and meet their requirements.

2022-01-21

View All Reviews

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started